ATLAS / Macro Radar / Reporting / ELOX

Eloxx Pharmaceuticals, Inc. (ELOX) reporting calendar

Eloxx Pharmaceuticals, Inc. files periodic reports with the SEC as ELOX on Nasdaq. Atlas tracks 62 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
15 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
62

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ELOX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001193125-26-204722
10-K31 Dec 202517 Mar 202676 days0001193125-26-108687
10-Q30 Sep 202313 Nov 202344 days0000950170-23-062940
10-Q30 Jun 202311 Aug 202342 days0000950170-23-041837
10-Q31 Mar 202312 May 202342 days0000950170-23-021821
10-K31 Dec 202231 Mar 202390 days0000950170-23-011360
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024490
10-Q30 Jun 202212 Aug 202243 days0001564590-22-029339
10-Q31 Mar 20226 May 202236 days0001564590-22-018586
10-K31 Dec 202130 Mar 202289 days0001564590-22-012683
10-Q30 Sep 20218 Nov 202139 days0001564590-21-055313
10-Q30 Jun 202116 Aug 202147 days0001564590-21-044626
10-Q31 Mar 20217 May 202137 days0001564590-21-025356
10-K31 Dec 202012 Mar 202171 days0001564590-21-012703
10-Q30 Sep 20206 Nov 202037 days0001564590-20-051711
10-Q30 Jun 20207 Aug 202038 days0001564590-20-038092
10-Q31 Mar 20208 May 202038 days0001564590-20-023543
10-K31 Dec 20196 Mar 202066 days0001564590-20-009148
10-Q30 Sep 20196 Nov 201937 days0001564590-19-041002
10-Q30 Jun 20197 Aug 201938 days0001564590-19-029697
10-Q31 Mar 20199 May 201939 days0001564590-19-017648
10-K31 Dec 201814 Mar 201973 days0001564590-19-007811
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028309
10-Q30 Jun 201810 Aug 201841 days0001564590-18-021183
10-Q31 Mar 201810 May 201840 days0001193125-18-159256
10-K31 Dec 201716 Mar 201875 days0001193125-18-086028
10-Q30 Sep 201714 Nov 201745 days0001144204-17-059104
10-K30 Jun 201713 Oct 2017105 days0001144204-17-052475
10-Q31 Mar 201722 May 201752 days0001144204-17-028931
10-Q31 Dec 201610 Feb 201741 days0001144204-17-007403
10-Q30 Sep 201614 Nov 201645 days0001144204-16-134343
10-K30 Jun 201613 Oct 2016105 days0001144204-16-128038
10-Q31 Mar 201612 May 201642 days0001144204-16-101221
10-Q31 Dec 201516 Feb 201647 days0001144204-16-082378
10-Q30 Sep 201516 Nov 201547 days0001144204-15-065800
10-K30 Jun 20159 Oct 2015101 days0001144204-15-058919
10-Q31 Mar 201514 May 201544 days0001144204-15-030595
10-Q31 Dec 201417 Feb 201548 days0001144204-15-010034
10-Q30 Sep 201414 Nov 201445 days0001144204-14-068712
10-K30 Jun 201429 Sep 201491 days0001144204-14-058176

Source: SEC EDGAR company submissions for CIK 0001035354. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.